Literature DB >> 11123092

Laboratory testing in the evaluation and diagnosis of vasculitis.

M L Cuellar1, L R Espinoza.   

Abstract

A multitude of tests are available for the diagnosis and management of the vasculitides. Most of them are nonspecific but provide useful information that, when appropriately used in conjunction with the patient's history and physical examination can be of great assistance in arriving at a final diagnosis. In addition, information gathered may be of great help in monitoring disease activity and clinical response to therapy, in indicating the presence of specific organ system involvement, in monitoring toxicity of medication used, and in assessing prognosis. Serial measurements of acute phase reactants, complete blood cell count with differential, biochemistry profiles, urinalysis, and C3 and C4 levels should be obtained in all patients. Antineutrophil cytoplasmic antibodies (ANCA) determination provides valuable information and is highly specific for the diagnosis of small-vessel vasculitides, particularly Wegener's granulomatosis and microscopic polyangiitis. ANCA levels can be particularly useful to assess disease activity in these disorders. Hepatitis-B and, more importantly, hepatitis-C testing is extremely useful, particularly in the presence of liver involvement and associated risk factors. Angiographic studies may confirm the diagnosis, particularly if there is laboratory and clinical evidence of specific organ involvement. It should be noted, however, that angiography may be normal even when vasculitis is present, or the findings may be nonspecific. A definite diagnosis is provided by a tissue biopsy. This should be performed whenever there is access to clinically affected tissue.

Entities:  

Mesh:

Year:  2000        PMID: 11123092     DOI: 10.1007/s11926-000-0042-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  30 in total

Review 1.  Approach to the patient with suspected vasculitis.

Authors:  M D Cohen; D L Conn
Journal:  Bull Rheum Dis       Date:  1999

2.  [Horton's temporal arteritis: diagnosis using color Doppler ultrasonography].

Authors:  S Arrigucci; G Fantozzi; F Riello; M Bicchi; P Tanganelli; R Cappelli; S Forconi
Journal:  Minerva Cardioangiol       Date:  1998-09       Impact factor: 1.347

Review 3.  Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis.

Authors:  J C Jennette; R J Falk
Journal:  Curr Opin Rheumatol       Date:  1992-02       Impact factor: 5.006

Review 4.  Hepatitis C-associated autoimmune disorders.

Authors:  R W McMurray
Journal:  Rheum Dis Clin North Am       Date:  1998-05       Impact factor: 2.670

5.  Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?

Authors:  M Noris; E Daina; S Gamba; S Bonazzola; G Remuzzi
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Relationship between ANCA and disease activity in small vessel vasculitis patients with anti-MPO ANCA.

Authors:  J Ara; E Mirapeix; R Rodriguez; A Saurina; A Darnell
Journal:  Nephrol Dial Transplant       Date:  1999-07       Impact factor: 5.992

Review 7.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Authors:  J Savige; D Gillis; E Benson; D Davies; V Esnault; R J Falk; E C Hagen; D Jayne; J C Jennette; B Paspaliaris; W Pollock; C Pusey; C O Savage; R Silvestrini; F van der Woude; J Wieslander; A Wiik
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

8.  Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.

Authors:  E Uchio; T Matsumoto; S I Tanaka; S Ohno
Journal:  Clin Exp Rheumatol       Date:  1999 Mar-Apr       Impact factor: 4.473

9.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

10.  Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.

Authors:  A B Federici; R I Fox; L R Espinoza; T S Zimmerman
Journal:  Arthritis Rheum       Date:  1984-09
View more
  6 in total

1.  Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.

Authors:  Shen-Ju Gou; Jun Yuan; Chen Wang; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

Review 2.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 3.  Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.

Authors:  Theo Dov Golan
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

4.  Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview.

Authors:  Elias Toubi; Aharon Kessel; Ellen Bamberger; Theo Dov Golan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

5.  Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients.

Authors:  Sherif M Gamal; Sally S Mohamed; Marwa Tantawy; Ibrahem Siam; Ahmed Soliman; Marwa H Niazy
Journal:  Arch Rheumatol       Date:  2021-10-12       Impact factor: 1.472

Review 6.  Associations and Outcomes Between Chronic Traumatic Encephalopathy and Vasculitis in Adult Patients.

Authors:  Dennis Adjepong; Bilal Haider Malik
Journal:  Cureus       Date:  2020-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.